---
schema_version: "secwatch.filing_event.v1"
accession: "0001935979-26-000053"
form_type: "8-K"
ticker: "BHVN"
cik: "0001935979"
company_name: "Biohaven Ltd."
filed_at: "2026-07-09T21:11:27+00:00"
generated_at: "2026-07-09T21:12:08.250110+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Biohaven CSO Bruce Car retires to part-time Chief Innovation Officer; Pirman promoted to EVP Discovery

## Summary
- Bruce Car retires as CSO, becomes part-time Chief Innovation Officer effective July 13, 2026, focusing on external collaborations including Bexorg.
- David Pirman promoted to EVP and Head of Discovery, leading internal drug-discovery organization.
- Warren Volles, General Counsel and Chief Legal Officer, designated an executive officer.
- Dr. Car's salary reduced by 50% to reflect part-time work schedule.

## SEC filing metadata
- accession: 0001935979-26-000053
- form_type: 8-K
- ticker: BHVN
- cik: 0001935979
- company_name: Biohaven Ltd.
- filed_at: 2026-07-09T21:11:27+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1935979/000193597926000053/0001935979-26-000053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1935979/000193597926000053/bhvn-20260709.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001935979-26-000053
- JSON: https://secwatch.observer/filing/0001935979-26-000053.json
- Plain text: https://secwatch.observer/filing/0001935979-26-000053.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.